Planned intervention: On Tuesday, November 17th between 08:00-08:15 (UTC), Zenodo will be unavailable for 10 minutes because of a scheduled upgrade of our server infrastructure.

Published September 3, 2025 | Version v1

Publication Open

IN SILICO INVESTIGATION OF 3,6-DIPHENYL-[1,2,4]TRIAZOLO[3,4-B][1,3,4]THIADIAZOLE DERIVATIVES AS EGFR MODULATORS FOR LUNG CANCER TREATMENT

The Cancer Research Review

Contributors

Editor:

Muhammad Amir Abbas* Institute of Chemistry, The Islamia University Bahawalpur (IUB), Punjab, Pakistan; Corresponding Author E-mail: muhammadamirabbas@gmail.com Jamaluddin Mahar Department of Chemistry, Qaid-E-Azam University, Pakistan; jamaluddin@uos.edu.pk Muhammad Javed Khan Department of pharmacy The Aga Khan University Hospital, Islamabad, Pakistan; medicinexpert.27@gmail.com Muhammad Shahid Rasool Department of Chemistry, University of Karachi, Pakistan; ms.shahidrasool788@gmail.com Muhammad Zahid Khan Department of Peadtric Medicine, Nishtar Medical University Multan, Punjab, Pakistan; dr.mzkhan85744@gmail.com

Files

In Silico Investigation of 3,6-Diphenyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole Derivatives as EGFR Modulators for Lung Cancer Treatment.pdf

Files (3.9 MB)

Name	Size
In Silico Investigation of 3,6-Diphenyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole Derivatives as EGFR Modulators for Lung Cancer Treatment.pdf md5:1de35dbfb9f6099a9450af55250fd9da	3.9 MB	Preview Download

Additional details

Repository URL: https://the-crr.com/index.php/CRR/issue/view/10

56

Views

288

Downloads

Show more details

	All versions	This version
Views	56	56
Downloads	288	288
Data volume	1.1 GB	1.1 GB

More info on how stats are collected....

DOI

Resource type

Publication

Publisher

Zenodo

License: Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more

Technical metadata

Created: September 3, 2025
Modified: September 3, 2025